Although overall incidence rate has declined slightly in recent years, increases in the incidence in certain subgroups emphasize the importance of early diagnosis, risk-based screening, and PrEP for at-risk individuals.
Intravenous (IV) fosfomycin offers a novel therapeutic option in the treatment of systemic multi-drug resistant (MDR) infections. Unanswered questions remain regarding its efficacy and specific role in our therapeutic arsenal.
In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.
Clinically, C kroppenstedtii has been isolated largely from female subjects, with most samples resulting from breast tissue and the remainder identified in blood, sputum, lung, and prosthetic valve infections.